E2	Procedure:T2 Name:T31
E3	Modifier:T3 Modifies:T32
E4	Condition:T4 Name:T32
E5	Procedure:T5 Name:T33
E6	Modifier:T6 Modifies:T33
E9	Eq-Comparison:T9 Temporal-Period:T34
E11	Procedure:T11 Name:T35 Temporality:E9
E12	Eq-Comparison:T12 Temporal-Period:T36
E13	Procedure:T13 Name:T60 Temporality:E12
E14	Procedure:T14 Name:T37
E15	Procedure:T15 Name:T38
E16	Condition:T16 Name:T39
E17	Allergy:T17 Name:E18 Name2:E19 Name3:E22
E18	Drug:T18 Name:T41
E19	Drug:T19 Name:T42
E22	Drug:T22 Name:T45
E23	Condition:T23 Name:T47 Severity:T46
E24	Observation:T24 Name:T48 Temporality:E25 Numeric-Filter:E26
E25	Eq-Comparison:T25 Operator:T49 Value:T50 Temporal-Unit:T51
E26	Eq-Comparison:T26 Operator:T52 Value:T53
E27	Observation:T27 Name:T54 Duration:E29
E29	Eq-Comparison:T29 Value:T55 Temporal-Unit:T56 Operator:T28
E30	Modifier:T57 Modifies:T33
E8	Coreference:T8 Refers-To:E4
E31	Modifier:T58 Modifies:E8
E32	Negation:T59 Negates:E31
E10	Modifier:T10 Modifies:T35
E21	Modifier:T21 Modifies:T45
E28	Modifier:T43 Modifies:T54
T2	Procedure 37 43	biopsy
T3	Modifier 51 90	metastatic cervical nodal squamous cell
T4	Condition 91 100	carcinoma
T5	Procedure 106 108	CT
T6	Modifier 116 120	neck
T9	Eq-Comparison 215 222	Planned
T11	Procedure 248 266	PET CT examination
T12	Eq-Comparison 272 279	Planned
T13	Procedure 292 301	care exam
T14	Procedure 308 318	anesthesia
T15	Procedure 324 353	oropharyngeal surgical biopsy
T16	Condition 379 387	Pregnant
T17	Allergy 405 412	allergy
T18	Drug 416 419	FDG
T19	Drug 421 433	fluciclovine
T22	Drug 451 466	contrast agents
T23	Condition 479 496	renal dysfunction
T24	Observation 498 522	glomerular filtrate rate
T25	Eq-Comparison 524 538	within 30 days
T26	Eq-Comparison 540 552	less than 30
T27	Observation 581 593	lying supine
T29	Eq-Comparison 621 633	up to 1 hour
T30	Life-Stage-And-Gender 25 31	Adults
T31	Procedure-Name 37 43	biopsy
T32	Condition-Name 91 100	carcinoma
T33	Procedure-Name 106 108	CT
T34	Eq-Temporal-Period 215 222	Planned
T35	Procedure-Name 248 266	PET CT examination
T36	Eq-Temporal-Period 272 279	Planned
T37	Procedure-Name 308 318	anesthesia
T38	Procedure-Name 324 353	oropharyngeal surgical biopsy
T39	Condition-Name 379 387	Pregnant
T40	Life-Stage-And-Gender 388 393	women
T41	Drug-Name 416 419	FDG
T42	Drug-Name 421 433	fluciclovine
T45	Drug-Name 451 466	contrast agents
T46	Severity 472 478	Severe
T47	Condition-Name 479 496	renal dysfunction
T48	Observation-Name 498 522	glomerular filtrate rate
T49	Eq-Operator 524 530	within
T50	Eq-Value 531 533	30
T51	Eq-Temporal-Unit 534 538	days
T52	Eq-Operator 540 549	less than
T53	Eq-Value 550 552	30
T54	Observation-Name 581 593	lying supine
T55	Eq-Value 627 628	1
T56	Eq-Temporal-Unit 629 633	hour
T57	Modifier 126 134	contrast
T8	Coreference 202 209	disease
T58	Modifier 172 198	primary oropharyngeal site
T59	Negation 145 148	not
T10	Modifier 240 247	18F-FDG
T60	Procedure-Name 292 301	care exam
T21	Modifier 438 450	iodine-based
T28	Eq-Operator 621 626	up to
T43	Modifier 595 616	relatively motionless
A1	Life-Stage-And-Gender-Type T30 adult
A2	Eq-Temporal-Period-Value T34 future
A3	Eq-Temporal-Period-Value T36 future
A4	Life-Stage-And-Gender-Type T40 female
A6	Severity-Value T46 severe
A7	Observation-Type-Value E24 lab
A8	Eq-Operator-Value T49 LTEQ
A9	Eq-Temporal-Unit-Value T51 day
A10	Eq-Operator-Value T52 LT
A11	Eq-Temporal-Unit-Value T56 hour
A5	Eq-Operator-Value T28 LTEQ
R1	Found-By Arg1:E4 Arg2:E2
R2	Treatment-For Arg1:E5 Arg2:E8
R3	Using Arg1:E13 Arg2:E14
R4	Using Arg1:E13 Arg2:E15
R5	If-Then Arg1:E16 Arg2:T40
R6	Equivalent-To Arg1:E24 Arg2:E23
R7	And Arg1:T30 Arg2:E4
R8	And Arg1:E6 Arg2:E30
R9	Or Arg1:E19 Arg2:E22
R10	And Arg1:E14 Arg2:E15
R11	Or Arg1:E18 Arg2:E19
T1	Contraindication 559 580	Inability to tolerate
E1	Contraindication:T1 Contraindicates:E27
